BHA
LABU icon

Beech Hill Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Beech Hill Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-449
Closed -$759K – 73
2015
Q4 		$759K Buy
+449
New +$727K 0.48% 44

Other funds holding LABU

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Beech Hill Advisors's LABU Position: Q1 2016 in Review

Beech Hill Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2016, closing a stake of 449 shares — an estimated $759K sold.

Beech Hill Advisors first reported a position in LABU in Q4 2015 and held it in 1 quarter. The position peaked at $759K in Q4 2015. 21 funds tracked by Wall St. Rank hold LABU as of Q1 2016.

  • Beech Hill Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2016 after selling out during the quarter.
  • Beech Hill Advisors sold 449 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2016, an estimated $759K.
  • Beech Hill Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and held it in 1 quarter.
  • Beech Hill Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $759K in Q4 2015.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2016.

Based on Beech Hill Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.